Pricing Log in Create free account

Atara Biotherapeutics, Inc. (ATRA) vs Milestone Pharmaceuticals Inc. (MIST)

Atara Biotherapeutics, Inc. and Milestone Pharmaceuticals Inc. are both Biotechnology companies. Atara Biotherapeutics, Inc. and Milestone Pharmaceuticals Inc. are of similar size ($98.9M and $96.9M). Atara Biotherapeutics, Inc. has the higher net margin (−269.4% vs −1,586.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Atara Biotherapeutics, Inc. leads on 11 and Milestone Pharmaceuticals Inc. on 3.

Valuation

Metric ATRA MIST Biotechnology median
P/E n/m n/m 8.50
P/S 22.28 18.59 9.71
P/B n/m 5.41 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.16 0.64
EV/Sales 20.69 (2.44) 9.21
Earnings yield (12.85%) (97.18%) (33.15%)
Free cash flow yield (15.24%) (62.60%) (25.50%)

Profitability

Metric ATRA MIST Biotechnology median
Gross margin 91.38% 13.27% 65.16%
Operating margin (229.67%) (1,479.69%) 0.00%
Net margin (269.42%) (1,586.01%) 0.00%
Free cash flow margin (353.49%) (1,163.79%) 0.00%
Return on equity 46.33% (35,522.62%) (56.36%)
Return on assets (57.62%) (73.36%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ATRA MIST Biotechnology median
Revenue growth (TTM) (96.72%) — 6.02%
EPS growth (last fiscal year) 122.52% (11.94%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ATRA MIST Biotechnology median
Debt to equity 0.00 3.25 0.00
Current ratio 1.98 8.13 4.72
Net debt to EBITDA (0.22) 0.79 0.96

Dividend

Metric ATRA MIST Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ATRA MIST Biotechnology median
Market cap 96.86m 98.91m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack